Cargando…
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis
Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease with ursodeoxycholic acid (UDCA) as first-line treatment. Poor response to UDCA is associated with a higher risk of progressing to cirrhosis, but the underlying mechanisms are unclear. UDCA modulates the composition of primary...
Autores principales: | Martinez-Gili, Laura, Pechlivanis, Alexandros, McDonald, Julie A.K., Begum, Sofina, Badrock, Jonathan, Dyson, Jessica K., Jones, Rebecca, Hirschfield, Gideon, Ryder, Stephen D., Sandford, Richard, Rushbrook, Simon, Thorburn, Douglas, Taylor-Robinson, Simon D., Crossey, Mary M.E., Marchesi, Julian R., Mells, George, Holmes, Elaine, Jones, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190197/ https://www.ncbi.nlm.nih.gov/pubmed/37191344 http://dx.doi.org/10.1080/19490976.2023.2208501 |
Ejemplares similares
-
Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cells
por: Mulcahy, Victoria, et al.
Publicado: (2023) -
The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study
por: Jones, David E.J., et al.
Publicado: (2022) -
British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis
por: Chapman, Michael Huw, et al.
Publicado: (2019) -
The inter‐relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis
por: Dyson, J. K, et al.
Publicado: (2016) -
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis
por: Harms, Maren H, et al.
Publicado: (2020)